Takeda To Pay $13.6M Over Antidepressant Drug Kickbacks
Takeda Pharmaceuticals will pay $13.6 million to end allegations that it caused false Medicaid claims by providing kickbacks to healthcare providers to push prescriptions of its antidepressant drug Trintellix, the U.S. Department...To view the full article, register now.
Already a subscriber? Click here to view full article